• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services


  • Print
  • Share
  • E-mail

Interferon alfa-2b Product Approval Information - Licensing Action 11/6/97

Proper name: Interferon alfa-2b
Tradename: Intron A
Manufacturer: Schering Corp, Kenilworth, NJ, License #0994
Indication for Use: Use in conjunction with chemotherapy in patients with follicular lymphoma
Approval Date: 11/6/1997
Type of submission: Biologics license supplement


Clinical Review (PDF)
Labeling (PDF)